Observation of the therapeutic effect of apatinib in advanced platinum-resistant recurrent epithelial ovarian cancer

BACKGROUND: Apatinib is an oral anti-angiogenic drug that mainly targets vascular endothelial growth factor receptor 2 (VEGFR-2) and is widely used in a variety of solid tumours. The purpose of this study is to evaluate the clinical efficacy and safety of apatinib in patients with advanced platinum-...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Zhongmian, Luo, Zhongbin, He, Hongying, Chen, Yujie, Zhao, Bingbing, Yang, Zhijun, Li, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9948331/
https://www.ncbi.nlm.nih.gov/pubmed/36823642
http://dx.doi.org/10.1186/s13048-022-01055-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9948331/
https://www.ncbi.nlm.nih.gov/pubmed/36823642
http://dx.doi.org/10.1186/s13048-022-01055-4

Ejemplares similares